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1. Introduction
  Free radicals are the highly reactive species capable of 
wide spread, indiscriminate oxidation and peroxidation 
of proteins, lipids and DNA which can lead to significant 
cellular damage, the involvement of free radicals in 
pathological process such as aging, behavioural and 
psychiatric disorders, cancer, atherosclerosis and 
rheumatoid arthritis is well recognized[1]. Antioxidant reacts 
with reactive oxygen species (ROS) to quench the radicals 
and to produce less aggressive chemicals species likely to 
cause tissue damage. Much attention has been focused on 
the use of antioxidants because of their protective effect 
against damage from reactive oxygen species, on this basis 
the beneficial effect of antioxidants are being increased[2]. 
It is now widely recognized that the antioxidants are also 
useful in treatment of cancer. The changes in the base 
pair sequence of genetic material (either DNA or RNA) is 
called mutations, mutations can be caused by copying 
errors in the genetic material during cell division and/or by 
exposure to ultraviolet and/or ionizing radiation, chemical 
mutagens, viruses or it can also occur deliberately under 
cellular control during processes such as meiosis or DNA 
replication[3-5]. One of the best ways to minimize the effect 
of a mutagen is by the use of anticlastogens; they act by 
interfering with DNA repair and/or with mutagen metabolites 
and/or with free radicals.
  Naturally occurring substances from plant origin and 
dietary components have been widely studied for the 
antimutagenic activity, which includes phenolics, pigments, 
allylsulphides, glucosinolytes, anthocyans, phytosterols, 
protease inhibitors, phytoestrogens, carotenoids, flavonoids, 
tea-polyphenols, vitamins, cucuminoids, tannins, 
coumarins, chlorophyllin, porphyrins and alkylresorcinols 
from cereal grains[6]. The anticlastogenic phytochemicals 
also play an important role in prevention of cancer. 
Hence there is a need to establish the relations between 
antioxidants and anticlastogenic agents[7].
  Terminalia arjuna (Combretaceae) (T. arjuna) is an 
Objective: The alcoholic extract of stem bark of Terminalia arjuna (ALTA) was screened for 
antioxidant and antimutagenic (anticlastogenic) activity. Methods: Antioxidant property was 
determined by 1,1,Diphynyl,2-Picryl hydrazyl (DPPH) assay, super oxide radical scavenging 
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Ciocalteau’s reagent. Antimutagenic activity was evaluated using micronucleus test in mice. 
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erythrocytes (NCE) and also shown significant reduction in P/N ratio. Conclusions: These results 
suggested that ALTA possess significant antioxidant and antimutagenic activity.
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evergreen large decidous tree; the plant has been reported 
to be used in ayurvedic system of medicine for derangement 
of all the three humours kafa, pitta, vayu and all types 
of cardiac failure[8], dropsy, diuretics, antiinfective[9], 
antiasthamatic, treatment of rheumatoid arthritis and 
treatment of cancer[10]. Keeping in mind the great medicinal 
value of T. arjuna and its high content of polyphenols, 
flavones and flavonoids, present study was planned to 
investigate the antimutagenic effect of ALTA.
2. Materials and methods
2.1. Drugs and chemicals
  Analytical grade petroleum ether, 95% ethanol, distilled 
water, methanol (AR Grade, Rankem, S.A.S nagar), 
cyclophosphamide (Sigma, Germany), bovine albumin 
fraction-V (Otto kemi, Mumbai), geimsa’s stain (Loba 
Chemi, Mumbai), May-Gruenwald’s stain (Loba Chemi, 
Mumbai) and  sodium azide (Loba Chemi, Mumbai) were 
used for the study.
2.2. Plant material
2.2.1. Collection and identification of plant material 
  The dried bark of T. arjuna was obtained from the 
Natural Remedies Ltd. Bangalore and it was authenticated 
by Dr. H.B. Singh, Head, Raw Material Herbarium & 
Museum, National Institute of Science Communication and 
Information Resources, New Delhi. 
2.2.2. Extraction of plant material
  The shade dried plant material was powdered. The 
coarse powder was subjected to successive extraction with 
petroleum ether, alcohol (95%) in soxhlet apparatus (at 60-
80 曟) and the marc obtained after alcoholic extraction was 
macerated with distilled water to obtain an aqueous extract.
2.2.3. Phytochemical investigation
  The alcoholic (ALTA) and aqueous extracts (AQTA) 
of T. arjuna bark obtained were subjected to various 
phytochemical tests for identification of secondary 
metabolites present in them[11].
2.2.4. Determination of total polyphenols
  The total polyphenol content (TPC) was determined by 
spectrophotometry, using tannic acid as standard, according 
to the method described by the International Organization 
for Standardization (ISO) 14502-1. Briefly, 1.0 mL of the 
diluted sample extract was transferred in duplicate to 
separate tubes containing 5.0 mL of a 1/10 dilution of Folin-
Ciocalteu’s reagent in water. Then, 4.0 mL of a sodium 
carbonate solution (7.5% w/v) was added. The tubes were 
then allowed to stand at room temperature for 60 min before 
absorbance at 765 nm was measured against water. The 
concentration of polyphenols in samples was derived from a 
standard curve of tannic acid ranging from 10 to 50 毺g/mL 
and expressed in terms percentage[10].
2.3. Experimental animals
  Wistar rats (200 to 250g) and Swiss albino mice (18-22) 
purchased from Bioneeds, Tumkur for experimental purpose 
were all acclimatized for 7 days under standard husbandry 
conditions, i.e.; room temperature of (25依1) 曟; relative 
humidity of 45%-55% and a 12:12 h light/ dark cycle.
  All the experimental protocols were approved by 
Institutional Animal Ethical Committee (IAEC) of P.E.S 
College of Pharmacy, Bangalore (Karnataka) and were 
conducted in strict compliance according to ethical 
principles and guidelines provided by Committee for the 
Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA).
2.4. Acute toxicity studies
  Acute oral toxicity of the ALTA was determined by using 
female, nulliparous and non pregnant mice weighing 18-22 g. 
The animals were fasted for 3 h prior to the experiment. 
Up and down procedure OECD guideline No. 425 was 
adopted for toxicity studies (http://www.epa.gov/oppfead1/
harmonization/). Animals were administered with single 
dose of extract and observed for their mortality during 48 h 
(acute) and 14 days (chronic). LD50 was calculated as per 
OECD 425 using AOT 425 stat program. 
2.5. Antioxidant activity
2.5.1. DPPH assay[12]
  A working solution of methanolic DPPH (Sigma, Germany) 
having an absorbance of 0.9 at 516 nm was used. This was 
prepared by taking 150 毺L of stock solution (12.9 mg of 
DPPH in 10 mL of methanol) in 3 mL of methanol. To 150 毺L 
of DPPH solution in methanol, different concentrations of 
ascorbic acid were added and the total volume was made up 
to 3 mL with methanol. DPPH diluted to 3 mL was taken as 
blank. Decrease in absorbance in the presence of ascorbic 
acid was noted down at 516 nm after 15 min. A standard 
graph was plotted between concentration vs absorbance and 
EC50 values were calculated. The test solutions were treated 
in the similar manner and the EC50 values were calculated. 
2.5.2. Superoxide radical scavenging activity[13]
  It was carried out by using Nitro blue tetrazolium (NBT) 
reagent, the method is based on generation of super 
oxide radical (O2
-) by auto oxidation of hydroxylamine 
hydrochloride in presence of NBT, during the reaction the 
NBT is reduced to nitrite.
  In brief, aliquots of 0.1 to 1.0 mL to ascorbic acid solution 
were taken in a test tube, to which 1 mL of sodium 
carbonate, 0.4 mL of NBT and 0.2 mL of EDTA were added 
and zero minute reading was taken at 560 nm. The reaction 
was initiated by the addition of 0.4 mL of hydroxylamine 
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hydrochloride to the above solution. Reaction mixture was 
incubated at 25 曟 for 5 mins; the reduction of NBT was 
measured at 560 nm. A parallel control was also treated 
in the similar manner. All the extracts were treated in the 
similar manner, absorbance was recorded and EC50 values 
were calculated.  
2.5.3. Ferric chloride induced lipid peroxidation[14]
  Male albino rats (200 to 250 g) were sacrificed by cervical 
dislocation, the skin over the abdomen was cut open and the 
liver was perfused with ice cold 0.15 M KCl via portal vein. 
After perfusion, the liver was isolated and 20% (w/v) homogenate 
in 0.15 M KCl was prepared using tissue homogenizer 
under ice cold (0-4 曟) conditions. The homogenate was 
centrifuged at 1 500 g for 5 min and clear supernatant was 
used for further study. 
  Different concentrations of test extracts were taken in 
test tubes, to which 1 mL of 0.15 M KCl and 0.5 mL of cell 
free homogenate were added, peroxidation was initiated by 
adding 100 毺L of 1 mM ferric chloride. The mixture was 
incubated for 30 min at 37 曟. After incubation, the reaction 
was stopped by adding 2 mL of ice cold 0.25 N HCl containing 
15% trichloroacetic acid (TCA), 0.38% thiobarbituric acid 
(TBA) and 0.5% of 0.05% butylated hydroxyl toluene (BHT). 
The reaction mixture was heated for 60 min at 80 曟. The 
sample was cooled and centrifuged at 5 000 g for 15 min and 
absorbance of the supernatant was measured at 532 nm. 
  An identical experiment (control induced) was performed 
in absence of test compounds to determine the amount of 
lipid peroxidation obtained in the presence of inducing 
agents without any test compounds. A blank was performed 
with all the reagents except ferric chloride and test extracts.
% Anti lipid peroxidation effect (% ALP) was calculated 
using the equation: 
% ALP=1-
(Sample absorbance-Blank absorbance)
Absorbance of control
2.6. Antimutagenic activity
2.6.1. Micronucleus test in mice[15]
  Swiss albino mice of weight range 18-22 g were divided 
in to eleven groups (G1 to G11), each group consisting of 
six animals; the G1 - normal control group without any 
treatment, G2 - vehicle control received 2% acacia; G3, 
G4 and G5 were positive control groups challenged with 
cyclophosphamide (75 mg/kg, i.p.) and bone marrow samples 
were collected from these animals 24, 48 and 72 h after 
cyclophosphamide injection respectively. The animals in 
the groups G6 to G8 and G9 to G11 received ALTA 100 mg/kg and 
200 mg/kg, p.o. respectively for 7 consecutive days. On 7th 
day after the ALTA treatment all the animals in the group 
G6 to G11, were treated with cyclophosphamide and the 
bone marrow samples from G6, G7 and G8 were collected 
after 24, 48 and 72 h of cyclophosphamide administration, 
similarly from G9 , G10 and G11 group animals, the bone 
marrow samples were collected after 24, 48 and 72 h after 
the cyclophosphamide administration respectively; in brief, 
bone marrow was aspirated from femur into 1 mL of 5% 
bovine albumin in phosphate buffered saline (pH 7.2)[15-17].
The cell suspension was centrifuged (1 000 rpm for 5 min) 
and the smears were prepared from the pellet on chemically 
clean glass slides and stained with may-gruenwald and 
giemsa stain. The smears were analyzed under the oil 
immersion objective (100伊) for the presence of micronuclei 
(MN) in polychromatic erythrocytes and normochromatic 
erythrocytes (NCE). P/N (polychromatic erythrocytes/ 
normochromatic erythrocytes) ration was determined by 
counting a total of 500 erythrocytes per animal and total 
of 2 000 erythrocytes were examined for the presence of 
micronuclei per each animal sample[18].
2.7. Statistical analysis
  Values were expressed as mean依SEM from 6 animals. 
Statistical difference in mean will be analyzed using one 
way ANOVA followed by Turkey’s multiple comparison tests 
P < 0.05 were considered statically significant. 
3. Results 
3.1. Phytochemical investigation
  The phytochemical studies of T. arjuna revealed presence 
of carbohydrates, cardiac glycosides, phytosterols, fixed oils, 
amino acids, saponins, phenolic compounds and tannins  in 
the ALTA and carbohydrates, cardiac glycoside, proteins, 
amino acids, phenolic compounds and tannins in the AQTA.  
3.2. Determination of total polyphenols
  The estimation of polyphenolic content in the extracts 
revealed that, the ALTA and AQTA found to contain 90.33 % 
and 20.5% of polyphenolic compounds respectively. Based 
on very high polyphenolic content, only ALTA was selected 
for further studies.
3.3. Acute toxicity studies
  The acute oral toxicity study of ALTA produced mortality 
at 5 000 mg/kg and 2 000 mg/kg and no mortality observed 
at 550 mg/kg; the LD50 was calculated by using AOT-425 stat 
program and the calculated LD50 was found to be 1 098 mg/kg.  
3.4. Antioxidant activity
  The extracts containing varying quantities of total 
polyphenols and the monomeric polyphenols were 
comparatively studied for their antioxidant potentialities. 
Three different in vitro methods namely DPPH assay, super 
oxide radical scavenging activity and lipid peroxidation 
assay were employed, ascorbic acid was used as a standard. 
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In DPPH assay, the ALTA significantly decreased the 
absorbance produced by the DPPH and it was found to 
possess more significant antioxidant activity, however the 
activity is lesser then ascorbic acid. Where as the AQTA 
has moderately decreased the absorbance due to DPPH and 
which is not significant when compare to ALTA and ascorbic 
acid. In superoxide free radical scavenging activity, the 
ascorbic acid, ALTA and AQTA has offered good free radical 
scavenging activity by decreasing the absorbance due to 
NBT. In lipid peroxidation assay, the ALTA and ascorbic acid 
has significant inhibited of lipid peroxidation by decreasing 
the absorbance of the supernatant, where as it is not 
significant with AQTA when compare to ALTA and ascorbic 
acid. The results of antioxidant studies are shown in Table 1.
3.5. Antimutagenic activity
  The probability of spontaneous mutation was evaluated 
for untreated normal control group, vehicle control group 
treated with 2% acacia and ALTA treated groups, by 
Table 1
EC50 values of T. arjuna extracts in antioxidant studies.
Sl. No. Extract/Std
 EC50 valves
DPPH assay Super oxide scavenging activity Lipid peroxidation assay
1       Ascorbic acid   2.471依0.140 40.50依0.39   63.00依0.36
2       Alcoholic extract   2.491依0.160 50.11依0.15   71.00依0.25
3       Aqueous extract   4.910依0.790 59.94依0.16 299.00依0.32
All the values are expressed as Mean依 SEM, n = 6. 
 
Table 2 
Antimutagenic effect of ALTA after 24 h of clastogenic challenge.  
 Sl.No.  Group  %MNPCE  %MNNCE P/N ratio
1 Normal control   1.500依0.028      1.920依0.042 0.780依0.005
2 Vehicle control   (Acacia 2% in water)   1.460依0.035      1.870依0.038 0.780依0.024             
3 ALTA (100 mg/kg, p.o.)   1.480依0.023      1.810依0.041 0.810依0.023
4 ALTA (200 mg/kg, p.o.)   1.390依0.023      1.680依0.039 0.820依0.028
5 Cyclophosphamide (75 mg/kg, i.p.)    3.330依0.024*       9.550依0.059*  0.349依0.004*
6 ALTA (100 mg/kg, p.o.) +Cyclophosphamide (75 mg/kg, i.p.)    1.510依0.020a       4.720依0.029a  0.320依0.005b
7 ALTA (200 mg/kg, p.o.) +Cyclophosphamide (75 mg/kg, i.p.)    1.440依0.031a       5.070依0.032a  0.284依0.006b
All the values are expressed as Mean依 SEM, n = 6. *P< 0.001 vs normal control group, a P< 0.001, b P<0.05 vs cyclophosphamide after 24 hours 
of clastogenic challenge. 
 
Table 3
Antimutagenic effect of ALTA after 48 h of clastogenic challenge.      
Sl.No.  Group  %MNPCE  %MNNCE P/N ratio
1 Normal control   1.500依0.028  1.920依0.042   0.780依0.005
2 Vehicle control   (Acacia 2% in water)   1.460依0.035  1.870依0.038   0.780依0.024             
3 ALTA (100 mg/kg, p.o.)    1.480依0.023  1.810依0.041   0.810依0.023
4 ALTA (200 mg/kg, p.o.)    1.390依0.030  1.680依0.039   0.820依0.028
5 Cyclophosphamide (75 mg/kg, i.p.)     7.500依0.070* 10.800依0.061*   0.694依0.009
6 ALTA (100 mg/kg, p.o.) +Cyclophosphamide (75 mg/kg, i.p.)     1.740依0.037a   5.020依0.041a    0.346依0.010a
7 ALTA (200 mg/kg, p.o.) +Cyclophosphamide (75 mg/kg, i.p.)     1.580依0.032a   5.230依0.023a     0.302依0.002a
All the values are expressed as Mean依 SEM, n= 6. *P< 0.001 vs normal control group. aP< 0.001 vs cyclophosphamide.
 
Table 4
Antimutagenic effect of ALTA after 72 h of clastogenic challenge.      
Sl. No.  Group  %MNPCE  %MNNCE P/N ratio
1 Normal control   1.500依0.028   1.920依0.042   0.780依0.005
2 Vehicle control   (Acacia 2% in water)   1.460依0.035   1.870依0.038   0.780依0.024             
3 ALTA (100 mg/kg, p.o.)   1.480依0.023   1.810依0.041   0.810依0.023
4 ALTA (200 mg/kg, p.o.)   1.390依0.030     1.680依00.039   0.820依0.028
5 Cyclophosphamide (75 mg/kg, i.p.)    9.260依0.095*   11.450依0.087*   0.812依0.002
6 ALTA (100 mg/kg, p.o.) +Cyclophosphamide (75 mg/kg, i.p.)    2.102依0.031a    3.118依0.022a    0.674依0.010a
7 ALTA (200 mg/kg, p.o.) +Cyclophosphamide (75 mg/kg, i.p.)    1.932依0.042a    3.296依0.029a    0.586依0.008a
All the values are expressed as Mean依 SEM, n= 6. *P< 0.001 vs normal control group. a P< 0.001 vs cyclophosphamide.          
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collecting the bone marrow samples of the respective groups 
without cyclophosphamide treatment and the samples were 
evaluated for frequency of PCE’s, NCE’s and concurrently 
looked for frequency of MNPCE’s and MNNCE’s respectively 
and the P/N ratio was calculated.
  Similar to untreated group and vehicle treated 
groups, the positive control group animals treated with 
cyclophosphamide (75 mg/kg, i.p.) were evaluated for the 
frequency of MNPCE’s, MNNCE’s and P/N ratio after the 
24 h, 48 h and 72 h of cyclophosphamide administration; 
the observations showed that, there was a significant 
increase in the frequency of MNPCE’s and MNNCE’s, also 
there is increase in P/N ratio, at 24 h, 48 h and 72 h after 
cyclophosphamide administration compare to normal control 
group. 
  The antimutagenic activity of ALTA was evaluated 
by its inhibitory effect on cyclophosphamide induced 
mutagenesis. The ALTA at 100 and 200 mg/kg, p.o., has 
significantly decreased the frequency of MNPCEs and 
MNNCEs, also there is a significant decrease in P/N ratio, 
compare to corresponding positive control group treated with 
cyclophosphamide. The results are given in Table 2.
4. Discussion
  The present study was under taken to evaluate the 
antioxidant and antimutagenic activity of bark extracts of T. 
arjuna which have been not studied so far, The antioxidant 
potential of the extract was determined by three methods 
namely DPPH assay, super oxide radical scavenging activity 
and lipid peroxidation assay; antimutagenic activity was 
studied by using micronucleus test.
  The chemicals that damage the genetic material either 
by inducing chromosomal abnormalities (numerical and 
structural abnormalitites) and/or by damaging DNA, leading 
to mutation are described as genotoxic or clastogens. The 
mutations in somatic cells leading to pathological conditions 
such as carcinogenesis, atherosclerosis and other heart 
diseases, these are the leading causes of death in the human 
population[19, 20]. The mutagenic or clastogenic potential of 
a drug can be studied by using animal models like in vivo 
micronucleus test and chromosomal aberration test etc. The 
drugs that inhibit the clastogenic potential of a chemical or 
drug are called as antimutagens.
  ROS are the by products of normal cell metabolism 
during enzymatic electron-transporting processes, such as 
mitochondrial respiration and metabolism of xenobiotics by 
the microsomal system of monooxygenases. ROS can also 
be generated as the main products of membrane-bound 
NADPH oxidase in phagocytes. Under normal physiological 
conditions, when the functioning of antioxidant systems 
is adequate, ROS are probably of low hazard for an 
organism. However, there is an excessive increase in 
ROS generation under the influence of some exogenous or 
endogenous factors, and also when there is an insufficiency 
of antioxidant systems, which can result in development 
of oxidative stress, Oxidative stress is expressed as a 
disturbance of the stable equilibrium between pro-oxidant 
and antioxidant processes in a direction where pro-oxidant 
processes prevail. This disturbance leads to various types of 
damage at the molecular and cell level[21-23]; in such cases 
antioxidants can acts as stabilizers of homeostasis.
  It is well known that antioxidants are almost universal 
antimutagenic agents[ 24, 25]. A reason for this effect is the 
genotoxicity of reactive oxygen species. 
  In present study both ALTA and AQTA showed the 
significant antioxidant activity in all the experimental 
antioxidant models. However, the ALTA was found to 
possess more potent antioxidant activity compare to AQTA, 
may be because it’s high polyphenolic content. Based on 
the percentage of polyphenolic content and antioxidant 
potential, the ALTA was selected for evaluating the 
antimutagenic potential. 
  The antimutagenic potential of ALTA was determined 
b y  c y c l o p h o s p h a m i d e  i n d u c e d  m u t a g e n i c i t y . 
Cyclophosphamide is a well known anticancer agent 
belongs to the class of alkylating agents, it undergoes 
biotransformation to give active metabolites namely 
aldophsophamide and phosphoramide mustard; the initial 
metabolic step is activated by CYP2B6 (and, to a much 
lower extent by CYP3A4) and involves hydroxylation of 
oxazaphosphorine ring to generate carbinolamime[26]. 
The carbinolamine undergoes nonenzymatic hydrolysis 
to give aldophosphamise either in the blood stream or 
inside the cell, inside the cell the aldophosphamide will 
undergoes decomposition in to well known mutagens namely 
acrolein and phopharamide mustard[27]. Lethal adverse 
effects associated with cyclophosphamide usage includes 
immunosuppression, nephrotoxicity, carcinogenicity and 
mutagenicity, through its metabolites either by depleting the 
antioxidant levels, acting as pro-oxidant or/and by directly 
damaging the DNA of the host.  
  The mutagenicity of cyclophosphamide is associated 
w i t h  t h e  f o r m a t i o n  o f  t h e  u l t i m a t e  c y t o t o x i c 
metabol i te  phosphoramide mustard through the 
intermediate agents hydroxycyclophosphamide and 
deschloroethylcyclophosphamide, which is capable of 
inducing DNA crosslinks and strand lesions[27].
  The antimutagenic effect of ALTA observed on micronucleus 
test was highly significant at 100 and 200 mg/kg, p.o. but there 
was no significant difference between 100 and 200 mg/kg in 
there antimutagenic activity. The possible mechanism of 
action might be associated with detoxification of the toxic 
metabolites and/or scavenging of super oxide free radicals 
and/ or by altering the activation and detoxification of 
xenobiotics.
  Therefore, from the present study, it is concluded that 
alcoholic extract of T. arjuna can prove to be a very 
good antioxidant and effective chemopreventive against 
cyclophosphamide induced mutagenesis.   
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